These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6431834)

  • 1. Prediction of relapse with the TRH test and prophylactic amitriptyline in 39 patients with endogenous depression.
    Krog-Meyer I; Kirkegaard C; Kijne B; Lumholtz B; Smith E; Lykke-Olesen L; Bjørum N
    Am J Psychiatry; 1984 Aug; 141(8):945-8. PubMed ID: 6431834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of amitriptyline on the thyrotropin response to thyrotropin-releasing hormone in endogenous depression.
    Krog-Meyer I; Kirkegaard C; Kijne B; Lumholtz B; Smith E; Lykke-Olesen L; Bjørum N
    Psychiatry Res; 1985 Jun; 15(2):145-51. PubMed ID: 3929293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of TSH and prolactin responses to TRH as predictors of the therapeutic effect of ECT in depression.
    Lykouras L; Markianos M; Augoustides A; Papakostas Y; Stefanis C
    Eur Neuropsychopharmacol; 1993 Jun; 3(2):81-3. PubMed ID: 8364352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TSH response to TRH and ECT.
    Hofmann P; Gangadhar BN; Probst C; Koinig G; Hatzinger R
    J Affect Disord; 1994 Oct; 32(2):127-31. PubMed ID: 7829764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin and TSH responses to TRH and to ECT in pre- and postmenopausal women with major depression.
    Markianos M; Lykouras L; Stefanis C
    Biol Psychiatry; 1996 Sep; 40(5):403-6. PubMed ID: 8874842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid-stimulating hormone response to thyrotropin-releasing hormone in unipolar depression before and after clinical improvement.
    Extein I; Pottash AL; Gold MS; Silver JM
    Psychiatry Res; 1982 Apr; 6(2):161-9. PubMed ID: 6806836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrotrophin response to thyrotrophin-releasing hormone in unipolar and bipolar affective illness.
    Linkowski P; Brauman H; Mendlewicz J
    J Affect Disord; 1981 Mar; 3(1):9-16. PubMed ID: 6455462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of low-dose TRH on cognitive deficits in the ECT postictal state.
    Khan A; Mirolo MH; Claypoole K; Bhang J; Cox G; Horita A; Tucker G
    Am J Psychiatry; 1994 Nov; 151(11):1694-6. PubMed ID: 7943463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dexamethasone suppression and thyrotropin-releasing hormone tests and response to treatment in unipolar depression.
    Extein I; Kirstein LS; Pottash AL; Gold MS
    Int J Psychiatry Med; 1982-1983; 12(4):267-74. PubMed ID: 6820012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression.
    Rush AJ; Giles DE; Schlesser MA; Orsulak PJ; Weissenburger JE; Fulton CL; Fairchild CJ; Roffwarg HP
    Biol Psychiatry; 1997 May; 41(9):915-28. PubMed ID: 9110097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of repeated sleep deprivation on clinical symptoms and the TRH test in endogenous depression.
    Kvist J; Kirkegaard C
    Acta Psychiatr Scand; 1980 Nov; 62(5):494-502. PubMed ID: 6782834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of endogenous depression with oral thyrotropin-releasing hormone and amitriptyline.
    Karlberg BE; Kjellman BF; Kågedal B
    Acta Psychiatr Scand; 1978 Nov; 58(5):389-400. PubMed ID: 102114
    [No Abstract]   [Full Text] [Related]  

  • 13. Blunted TSH response to TRH and seizure duration in ECT.
    Papakostas YG; Markianos M; Pehlivanidis A; Zervas IM; Papadimitriou GN; Stefanis C
    Acta Psychiatr Scand; 1999 Jan; 99(1):68-72. PubMed ID: 10066009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
    Künzel HE; Ackl N; Hatzinger M; Held K; Holsboer-Trachsler E; Ising M; Kaschka W; Kasper S; Konstantinidis A; Sonntag A; Uhr M; Yassouridis A; Holsboer F; Steiger A
    J Psychiatr Res; 2009 Apr; 43(7):702-10. PubMed ID: 19038406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of electroconvulsive therapy on the thyrotropin-releasing hormone test in patients with depression.
    Esel E; Kilic C; Kula M; Basturk M; Ozsoy S; Turan T; Keles S; Sofuoglu S
    J ECT; 2004 Dec; 20(4):248-53. PubMed ID: 15591859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyrotropin responses to TRH and MHPG excretion before and after an electroconvulsive therapeutic course in depressed patients.
    Lykouras L; Markianos M; Hatzimanolis J; Malliaras D; Stefanis C
    Prog Neuropsychopharmacol Biol Psychiatry; 1992 Jul; 16(4):495-500. PubMed ID: 1641494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent neuroendocrine dysregulation in major depressive disorder: a marker for early relapse.
    Targum SD
    Biol Psychiatry; 1984 Mar; 19(3):305-18. PubMed ID: 6426529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The application of serial neuroendocrine challenge studies in the management of depressive disorder.
    Targum SD
    Biol Psychiatry; 1983 Jan; 18(1):3-19. PubMed ID: 6403062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine abnormalities in affective disorders.
    Extein I; Pottash AL; Gold MS
    Encephale; 1982; 8(2):203-11. PubMed ID: 6809445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of thyrotropin to thyrotropin-releasing hormone as predictor of treatment outcome. Prediction of recovery and relapse in treatment with antidepressants and neuroleptics.
    Langer G; Koinig G; Hatzinger R; Schönbeck G; Resch F; Aschauer H; Keshavan MS; Sieghart W
    Arch Gen Psychiatry; 1986 Sep; 43(9):861-8. PubMed ID: 2875702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.